According to Pacira Biosciences 's latest financial reports and stock price the company's current Operating Margin is -9.00%. At the end of 2024 the company had an Operating Margin of -7.09%.
Year | Operating Margin | Change |
---|---|---|
2024 | -7.09% | -160.53% |
2023 | 11.71% | 59.7% |
2022 | 7.33% | -53.52% |
2021 | 15.77% | 55.39% |
2020 | 10.15% | 282.43% |
2019 | 2.65% | -55% |
2018 | 5.90% | -165.5% |
2017 | -9.00% | -20.75% |
2016 | -11.36% | -406.45% |
2015 | 3.71% | -224.51% |
2014 | -2.98% | -95.59% |
2013 | -67.43% | -47.78% |
2012 | -129.14% | -47.44% |
2011 | -245.70% | 54.29% |
2010 | -159.25% | -16.29% |
2009 | -190.24% | -41.6% |
2008 | -325.77% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.